Karen J Chronister1,2, Nicholas Lintzeris3,4, Anthony Jackson1,3, Mihaela Ivan1,2, Paul M Dietze5, Simon Lenton6, John Kearley1,3, Ingrid van Beek1,7. 1. Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney, Australia. 2. Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, UNSW Australia, Sydney, Australia. 3. The Langton Centre, South Eastern Sydney Local Health District, Sydney, Australia. 4. Division of Addiction Medicine, Faculty of Medicine, University of Sydney, Sydney, Australia. 5. Burnet Institute, Melbourne, Australia. 6. National Drug Research Institute, Faculty of Health Sciences, Curtin University, Perth, Australia. 7. School of Public Health and Community Medicine, Faculty of Medicine, UNSW Australia, Sydney, Australia.
Abstract
INTRODUCTION AND AIMS: Opioid overdose prevention programs providing take-home naloxone have been expanding internationally. This paper summarises findings and lessons learnt from the Overdose Prevention and Emergency Naloxone Project which is the first take-home naloxone program in Australia implemented in a health care setting. METHODS: The Project intervention provided education and take-home naloxone to opioid-using clients at Kirketon Road Centre and The Langton Centre in Sydney. The evaluation study examined uptake and acceptability of the intervention; participants' knowledge and attitudes regarding overdose and participants' experience in opioid overdose situations six months after the intervention. Participants completed baseline, post-training and follow-up questionnaires regarding overdose prevention and management which were analysed using repeated measures analysis of variance. RESULTS:Eighty-three people participated in the intervention, with 35 (42%) completing follow-up interviews-51% reporting usingnaloxone with 30 overdoses successfully reversed. There were significant improvements in knowledge and attitudes immediately following training with much retained at follow-up, particularly regarding feeling informed enough (97%) and confident to inject naloxone (100%). DISCUSSION: Take-home naloxone programs can be successfully implemented in Australian health settings. Barriers to uptake, such as lengthy processes and misperceptions around interest in overdose prevention, should be addressed in future program implementation.
RCT Entities:
INTRODUCTION AND AIMS: Opioid overdose prevention programs providing take-home naloxone have been expanding internationally. This paper summarises findings and lessons learnt from the Overdose Prevention and Emergency Naloxone Project which is the first take-home naloxone program in Australia implemented in a health care setting. METHODS: The Project intervention provided education and take-home naloxone to opioid-using clients at Kirketon Road Centre and The Langton Centre in Sydney. The evaluation study examined uptake and acceptability of the intervention; participants' knowledge and attitudes regarding overdose and participants' experience in opioid overdose situations six months after the intervention. Participants completed baseline, post-training and follow-up questionnaires regarding overdose prevention and management which were analysed using repeated measures analysis of variance. RESULTS: Eighty-three people participated in the intervention, with 35 (42%) completing follow-up interviews-51% reporting using naloxone with 30 overdoses successfully reversed. There were significant improvements in knowledge and attitudes immediately following training with much retained at follow-up, particularly regarding feeling informed enough (97%) and confident to inject naloxone (100%). DISCUSSION: Take-home naloxone programs can be successfully implemented in Australian health settings. Barriers to uptake, such as lengthy processes and misperceptions around interest in overdose prevention, should be addressed in future program implementation.
Authors: Seonaid Nolan; Jane Buxton; Sabina Dobrer; Huiru Dong; Kanna Hayashi; M J Milloy; Thomas Kerr; Julio Montaner; Evan Wood Journal: Public Health Rep Date: 2017-07-27 Impact factor: 2.792
Authors: Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman Journal: Addict Behav Date: 2021-12-20 Impact factor: 4.591
Authors: Jermaine D Jones; Aimee N Campbell; Laura Brandt; Felipe Castillo; Rebecca Abbott; Sandra D Comer Journal: Subst Abus Date: 2020-08-19 Impact factor: 3.716
Authors: Toni Marie Rudisill; Alexandria J Ashraf; Herbert I Linn; Sheena Sayres; James E Jeffries; Kelly K Gurka Journal: Inj Prev Date: 2020-09-01 Impact factor: 3.770